Summary:
We are conducting a Major Depressive Disorder Study that is has an 8 week treatment period and a 2-week discontinuation period. Subjects who complete this study will be offered the option to participate in the long-term extension study. The study is for patients who suffer from recurrent Major Depressive Disorder as a primary diagnosis.
Qualified Participants Must:
• Be 18 to 75 years of age
•
Have a diagnosis of Major Depressive Disorder
Qualified Participants May Receive:
Qualified participants will receive study medication, study related physical exams, laboratories, ekg's (at no cost) and compensations for time and travel.